NCT06528301 2026-01-12A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell MalignanciesUmoja BiopharmaPhase 1 Recruiting106 enrolled
NCT05805605 2025-07-01Allo HSCT Using RIC and PTCy for Hematological DiseasesMasonic Cancer Center, University of MinnesotaPhase 2 Recruiting56 enrolled